Published in J Hypertens on April 01, 2013
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc Diabetol (2014) 0.91
Haemoglobin: subtle scavenger of nitric oxide and modulator of retinal blood flow. J Hypertens (2013) 0.78
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension (2003) 2.34
Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (2014) 2.12
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation (2012) 2.07
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol (2008) 1.92
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation (2005) 1.89
Rosuvastatin in diabetic hemodialysis patients. J Am Soc Nephrol (2011) 1.85
Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med (2009) 1.85
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med (2003) 1.83
Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol (2010) 1.77
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol (2010) 1.70
Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant (2007) 1.66
Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2007) 1.65
AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study. J Hypertens (2002) 1.63
Basal nitric oxide activity is an independent determinant of arteriolar structure in the human retinal circulation. J Hypertens (2011) 1.53
Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol (2013) 1.52
Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels. J Hypertens (2011) 1.51
Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension (2006) 1.51
23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension (2013) 1.51
Remodeling of retinal small arteries in hypertension. Am J Hypertens (2011) 1.50
Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation. Nephrol Dial Transplant (2010) 1.49
Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. Hypertens Res (2011) 1.49
Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics (2007) 1.47
Retracted Changes of radial diffusivity and fractional anisotropy in the optic nerve and optic radiation of glaucoma patients. ScientificWorldJournal (2012) 1.46
The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant (2004) 1.46
Direct comparison of the effects of valsartan and amlodipine on renal hemodynamics in human essential hypertension. Am J Hypertens (2003) 1.45
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis (2008) 1.44
New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens (2011) 1.44
Elevation of sympathetic activity by eprosartan in young male subjects. Am J Hypertens (2003) 1.42
Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects. J Hypertens (2002) 1.41
Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Kidney Int (2002) 1.41
Fourier analysis of the envelope of the ophthalmic artery blood flow velocity: age- and blood pressure related impact. Hypertension (2007) 1.41
Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome. Obesity (Silver Spring) (2010) 1.40
Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients. J Hypertens (2010) 1.39
Effect of aliskiren on vascular remodelling in small retinal circulation. J Hypertens (2015) 1.39
Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics. Nephrol Dial Transplant (2002) 1.39
High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene. J Hypertens (2007) 1.37
Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome. J Clin Hypertens (Greenwich) (2014) 1.37
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens (2012) 1.37
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens (2007) 1.36
Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension (2007) 1.33
External beam radiotherapy of choroidal metastases--final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol (2002) 1.32
(23)Na magnetic resonance imaging of tissue sodium. Hypertension (2011) 1.29
(Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension (2008) 1.27
Beyond salt: lifestyle modifications and blood pressure. Eur Heart J (2011) 1.24
Continuing regular exercise during pregnancy: effect of exercise volume on fetoplacental growth. Am J Obstet Gynecol (2002) 1.23
Dynamic activation of the anterior cingulate cortex during anticipatory anxiety. Neuroimage (2008) 1.23
Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J (2005) 1.22
Salt and hypertension: is salt dietary reduction worth the effort? Am J Med (2012) 1.22
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens (2002) 1.19
Glaucoma risk index: automated glaucoma detection from color fundus images. Med Image Anal (2010) 1.17
Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine. J Hypertens (2009) 1.13
Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke (2004) 1.12
MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol (2011) 1.12
Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. Hypertension (2004) 1.11
Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens (2008) 1.10
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens (2010) 1.09
Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens (2005) 1.08
Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens (2008) 1.08